John Ansell, Senior Partner, TranScrip Partners
Sultan Aziz, Senior Director, Capacity Management, Janssen Pharmaceuticals
Scott Babler, Strategic Realization Manager, Integrated Project Management Company, Inc.
Greg Bayer, Group Director, R&D Scheduling & Resource Management, Bristol-Myers Squibb
Richard Bayney, Ph.D., President & Founder, Project & Portfolio Value Creation; former Vice President, Portfolio Management & Decision Analysis, Johnson & Johnson
Joseph Billitti, Ph.D., MBA, Executive Director, Strategy and Operations, Global Research & Development, Pfizer
Pasquale Cetera, Consultant, MKTG Pharmaceuticals; former Vice President, Portfolio Management and Strategy, Merck
Jeffrey Davis, M.D., Director, Human Health and Performance (HH&P), CMO, NASA Johnson Space Center
Sydney Edwards, Ph.D., Head, Portfolio Management, Allergan, Inc.
Carmel Egan, Ph.D., Vice President, Project Management, Eli Lilly & Co.
Philip Fahringer, Analyst, Center for Innovation, Lockheed Martin
Jonathan Freeman, Ph.D., Senior Vice President, Head, Portfolio Management, Merck Serono
Keith Friend, Ph.D., Senior Director Medical Affairs, Otsuka (OAPI)
Krish Ghosh, Ph.D., Vice President, Informatics, Covance
Arkady Gusev, Ph.D., US Operations Head, Biomarker Development (BMD), Translational Medicine, Novartis Institutes for BioMedical Research, Inc.
Ling He, Director, Clinical Bioanalysis, Daiichi Sankyo Pharma Development
Hartmut Hein, Ph.D., Director, Global Planning Office, Merck KGaA
Rafiqul Islam, Senior Director, Global Bioanalytical Services, Celerion, Inc.
Elayne Ko, Director, Portfolio and Decision Analysis, Pfizer
William Korinek, Ph.D., Vice President, Worldwide R&D Business Operations, Pfizer
John LaMattina, Senior Partner, PureTech Ventures; former President, R&D, Pfizer
Sam Mathew, MBA, Portfolio Capacity Management Leader, Finance/PMO, Janssen Pharmaceuticals
Maureen McNamara, Executive Director, Global Project Management, Merck Research Laboratories
Carlos Nunes, Director, Portfolio & Decision Analysis, Portfolio & Commercial Operations, Pfizer
David Parker, Ph.D., Vice President, Market Access Strategy, Precision for Medicine
Dave Penndorf, Executive Consultant, Planisware USA
John Phillips, Director, Capital Efficiency, Business Valuation Consulting, Deloitte Transactions & Business Analytics
George Santangelo, Ph.D., Head, Office of Portfolio Analysis (OPA) , Division of Program Coordination, Planning, and Strategic Initiatives (DPCPSI), NIH
Michael Shires, Vice President, Program and Portfolio Management, Baxter Healthcare
Richard Sonnenblick, Ph.D., CEO, Enrich Consulting
Tom Stone, Lecturer in Business, Penn State University, Abington College
Bennet Vallet, Director, Product Development, Siemens
Phil Wolf, Senior Vice President, Enterprise and On Demand Products, PDWare
Daniel Zweidler, Ph.D., Senior Fellow, Mack Institute for Innovation Management, The Wharton School, UPenn; President, DZA, Inc.